944
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Cost-effectiveness of insulin detemir compared with NPH insulin in people with type 2 diabetes in Denmark, Finland, Norway, and Sweden

, , &
Pages 468-478 | Accepted 17 Jan 2013, Published online: 06 Feb 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Rhodri Saunders, Jean Lian, Boris Karolicki & William Valentine. (2014) The cost-effectiveness and budget impact of stepwise addition of bolus insulin in the treatment of type 2 diabetes: evaluation of the FullSTEP trial. Journal of Medical Economics 17:12, pages 827-836.
Read now

Articles from other publishers (9)

Nicolas Boespflug, Jérôme Wittwer & Antoine Bénard. (2023) Factors associated with the author-reported cost-effectiveness threshold in high-income countries: systematic review and multivariable modelling. The European Journal of Health Economics.
Crossref
Mohsen pakdaman, Raheleh akbari, Hamid reza Dehghan, Asra Asgharzadeh & Mahdieh Namayandeh. (2020) The cost-effectiveness of insulin analogs and regular insulin for diabetes control: a case study in Iran. International Journal of Health Care Quality Assurance 33:4/5, pages 323-331.
Crossref
Mohsen Pakdaman, Rahele Akbari, Hamid Reza Dehghan, Reza Valagohar, Parastoo Rostami & Mahdieh Namayandeh. (2019) The Cost-effectiveness of Analogue Insulin Pens in Comparison with Human Insulin Pens for Controlling Type 1, Type 2, and Gestational Diabetes: A Systematic Review Article. Health Technology Assessment in Action In Press:In Press.
Crossref
D.R. Torres, A. Portilla, M.E. Machado-Duque & J.E. Machado-Alba. (2017) Trends in the use and cost of human and analogue insulins in a Colombian population, 2011–2015. Public Health 153, pages 64-69.
Crossref
Asrul Akmal Shafie, Chin Hui Ng, Yui Ping Tan & Nathorn Chaiyakunapruk. (2016) Systematic Review of the Cost Effectiveness of Insulin Analogues in Type 1 and Type 2 Diabetes Mellitus. PharmacoEconomics 35:2, pages 141-162.
Crossref
G. Blair Sarbacker & Elizabeth M. Urteaga. (2016) Adherence to Insulin Therapy. Diabetes Spectrum 29:3, pages 166-170.
Crossref
Cristóbal Morales, Daniel de Luis, Antonio Ramírez de Arellano, Maria Giovanna Ferrario & Luis Lizán. (2015) Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain. Diabetes Therapy 6:4, pages 593-610.
Crossref
A. Vaag. (2015) Insulin is not insulin and a unit not a unit. Diabetes, Obesity and Metabolism 17:3, pages 217-218.
Crossref
José Miguel González-Clemente. (2014) Nuevos fármacos para la diabetes mellitus tipo 2: amigos o enemigos. Reflexiones sobre una nueva guía de «armonización» del tratamiento de la diabetes mellitus tipo 2. Avances en Diabetología 30:4, pages 91-94.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.